InMed Pharmaceuticals Inc...

3.29
-0.22 (-6.27%)
At close: Jan 30, 2025, 11:40 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue 4.60M 4.14M 1.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 39.66K 79.46K 168.42K 623.37K 1.74M 2.76M 4.23M 2.09M 185.61K 13.77K 2.44K
Cost of Revenue 3.50M 2.73M 545.89K 197.03K 183.09K 93.94K 92.78K n/a n/a n/a n/a n/a n/a n/a 8.76K 108.89K 405.58K 1.82M 1.42M 3.19M 1.20M 90.02K 17.16K 17.02K
Gross Profit 1.10M 1.40M 543.55K -197.03K -183.09K -93.94K -92.78K n/a n/a n/a n/a n/a n/a 39.66K 70.71K 59.53K 217.79K -80.56K 1.34M 1.04M 892.20K 95.59K -3.39K -14.58K
Operating Income n/a -8.18B -13.70M -9.92M -8.74M -10.36M -6.78M -3.44M -1.84M -3.45M -1.15M -49.19K -168.72K -387.56K -411.40K -777.00K -1.27M -1.77M -1.18M -1.99M -1.24M -1.28M -2.75M -4.25M
Interest Income 527.90K 492.44K 96.09K 16.02K 125.89K 330.44K 69.55K n/a n/a n/a n/a 10.45 16.71 -0.39 -0.05 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -7.67M -7.93M -18.60M -10.20M -8.68M -10.10M -6.71M -3.44M -1.84M -3.46M -1.15M -46.74K -189.92K -461.35K -515.65K -1.05M -1.50M -1.79M -1.20M -2.75M -1.51M -1.28M -2.79M -2.29M
Net Income -7.68M -7.95M -18.60M -10.20M -8.94M -10.01M -6.71M -3.44M -1.84M -3.46M -1.15M -46.74K -189.92K -325.47K -334.79K -1.06M -922.26K -1.87M -1.27M -2.78M -1.52M -1.23M -2.71M -4.27M
Selling & General & Admin 5.25M 5.85M 6.87M 4.48M 3.50M 6.00M 5.17M 2.79M 1.48M 2.62M 1.09M 46.75K 151.57K 314.36K 300.73K 536.37K 1.17M 1.31M 2.26M 2.58M 1.84M 995.66K 902.67K 3.91M
Research & Development 3.77M 3.73M 7.28M 5.34M 5.20M 4.30M 1.52M 573.72K 292.84K 759.85K 57.87K n/a 17.03K n/a 118.42K 116.94K 236.23K 212.64K n/a n/a n/a n/a n/a n/a
Other Expenses n/a -308.94K 185.66K 120.87K 161.97K 94.72K -0.00 75.22K 67.41K 75.76K -900.75 n/a n/a -73.79K -104.25K 237.90K 83.24K 169.63K 255.18K 453.18K 295.85K 380.70K 1.85M 329.67K
Operating Expenses 9.02B 9.78M 14.34M 9.94M 8.87M 10.39M 6.69M 3.44M 1.84M 3.46M 1.15M 46.75K 168.60K 427.21K 482.11K 836.53K 1.49M 1.69M 2.52M 3.03M 2.13M 1.38M 2.75M 4.24M
Interest Expense n/a n/a 96.09K 360.35K 18.62K n/a n/a 495.17 47.92 3.53K 1.69K 10.45 16.71 11.70K 27.63K 5.90K 230.10K 17.47K 20.14K 760.73K 267.57K n/a 32.91K n/a
Selling & Marketing Expenses -5.25B n/a n/a n/a 474.94K 706.23K n/a 844.27K 112.64K 498.44K 22.65K n/a n/a 27.36K 63.45K 97.00K n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 16.01B 12.51M 14.88M 9.94M 8.87M 10.39M 6.78M 3.44M 1.84M 3.46M 1.15M 46.75K 168.60K 427.21K 490.87K 945.42K 1.89M 3.51M 3.93M 6.22M 3.34M 1.47M 2.77M 4.26M
Income Tax 7.10K 13.10K 4.81M 360.35K 18.62K -262.10K -69.54K 495.17 47.92 3.53K 1.69K -2.46K 21.18K -73.79K -104.25K 791.78K -347.85K 99.59K 99.26K 816.12K 277.22K -50.37K -40.34K 15.51K
Shares Outstanding (Basic) 7.59M 2.45M 560.75K 270.00K 210.00K 210.00K 172.67K 108.43K 72.97K 55.87K 41.93K 40.84K 40.84K 17.43K 4.70K 3.78K 3.39K 2.55K 1.76K 1.07K 13.60K 3.67K 3.67K 3.67K
Shares Outstanding (Diluted) 7.59M 2.45M 560.83K 270.00K 210.00K 210.00K 172.67K 108.43K 72.97K 55.87K 41.93K 40.84K 40.84K 17.43K 4.70K 3.78K 3.41K 2.64K 1.76K 1.07K 13.60K 3.67K 3.67K 3.67K
EPS (Basic) -1.01 -3.25 -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -25.18 -61.89 -27.48 -1.14 -4.65 -18.68 -71.25 -280.6 -272.21 -735.56 -723.86 -2.60K -647.58 -334.98 -738.37 -1.16K
EPS (Diluted) -1.01 -3.25 -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -25.18 -61.89 -27.48 -1.14 -4.65 -18.68 -71.25 -280.6 -270.3 -711 -723.86 -2.60K -647.58 -334.98 -738.37 -1.16K
EBITDA -7.06M -10.83M -17.26M -9.80M -8.58M -10.26M -6.69M -3.36M -1.77M -3.38M -1.15M -46.75K -168.59K -252.04K -341.90K -608.24K -1.19M -973.42K -920.79K -1.54M -946.79K -900.07K -906.07K -2.04M
Depreciation & Amortization 604.52K 596.00K 511.79K 197.03K 183.09K 94.72K 89.60K 75.22K 67.41K 75.76K 40.30 2.44K 133.71 135.52K 69.50K 168.76K 83.24K 169.63K 252.49K 426.34K 295.85K 380.70K 1.85M 2.22M